Veterinary

Phibro Animal Health Corporation Declares Quarterly Dividend

Retrieved on: 
Tuesday, February 6, 2024
Veterinary, Other Consumer, Pets, Other Natural Resources, Other Health, Health, Consumer, Agriculture, Natural Resources, PAHC

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 27, 2024, to stockholders of record at the close of business on March 6, 2024.

Key Points: 

The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 27, 2024, to stockholders of record at the close of business on March 6, 2024.

Phibro Animal Health Corporation Announces Chief Financial Officer Changes

Retrieved on: 
Tuesday, February 6, 2024
Health, Consumer, Agriculture, Natural Resources, Pets, Pharmaceutical, Veterinary, Pfizer, Business administration, Financial system, Binghamton University, Knowledge, Senior, Master, IPO, Insurance, Initial public offering, PAHC, Management

Phibro Animal Health Corporation (Nasdaq: PAHC) (the “Company” or “Phibro”) today announced that Glenn C. David has joined Phibro and will assume the role of Chief Financial Officer effective February 9, 2024.

Key Points: 
  • Phibro Animal Health Corporation (Nasdaq: PAHC) (the “Company” or “Phibro”) today announced that Glenn C. David has joined Phibro and will assume the role of Chief Financial Officer effective February 9, 2024.
  • Mr. Richard Johnson, who is currently serving as Phibro’s interim Chief Financial Officer since September 29, 2023, will continue with Phibro for a period of time in an advisory capacity to ensure a smooth transition with his successor.
  • Glenn brings a wealth of knowledge and experience not only in financial matters but in the animal health industry which will be beneficial for Phibro as we continue to grow our business and bring value to our shareholders.
  • He brings the skills and experience needed to play a key role in Phibro’s future success,” said Jack Bendheim, Phibro’s Chairman, President, and Chief Executive Officer.

The World Market for Veterinary Diagnostics, 7th Edition - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 6, 2024
Veterinary, Health, Seventh Edition, Row, PRRS, Infection, Betaarterivirus suid 1, BVD, Clinical chemistry, Bovine viral diarrhea, Animal, IVD, Classical swine fever, TGE, Pet, Vaccine

The "World Market for Veterinary Diagnostics, 7th Edition" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "World Market for Veterinary Diagnostics, 7th Edition" report has been added to ResearchAndMarkets.com's offering.
  • Despite various challenges, the veterinary diagnostics market has shown consistent growth and is forecasted to continue on this trajectory.
  • The World Market for Veterinary Diagnostics, 7th Edition meticulously examines the global veterinary diagnostics market, focusing on two key components: companion animal (pets) diagnostics and food animal diagnostics.
  • The report provides a comprehensive analysis of major veterinary disease markets, offering insights into overall market performance and development.

Merck Animal Health to Acquire Elanco’s Aqua Business

Retrieved on: 
Monday, February 5, 2024
Biotechnology, Health, General Health, Pharmaceutical, Other Science, Research, Genetics, Fitness & Nutrition, Science, Veterinary, Clinical Trials, MSD, Schering-Plough, Elanco, PIT, Vaki, ELAN, MRK, Goldman Sachs, Covington & Burling, Water, Vaccine, Acquisition, Merck, Merck & Co., LLP, Aquaculture

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN) for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species; two related aqua manufacturing facilities in Canada and Vietnam; as well as a research facility in Chile.

Key Points: 
  • Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN) for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species; two related aqua manufacturing facilities in Canada and Vietnam; as well as a research facility in Chile.
  • “We are excited for the acquisition of Elanco’s aqua products, solutions as well as the capabilities and expertise the team brings to our business,” said Rick DeLuca, president, Merck Animal Health.
  • The addition of this innovative portfolio of cold water and warm water aqua products across vaccines, anti-parasitic treatments, water supplements and nutrition, will establish Merck Animal Health as a leader in aqua.”
    Elanco Animal Health President and CEO Jeff Simmons said, “Following a robust process over the last year, Merck Animal Health emerged as the right strategic buyer for the aquaculture business.
  • In March 2019, Merck Animal Health acquired Scan Aqua AS, a fish health and fish welfare company based in Norway, focused on key aqua products.

Hill’s Pet Nutrition and Bond Pet Foods Reach Milestone Toward Development of a More Sustainable Protein for Pet Foods

Retrieved on: 
Monday, February 5, 2024
Biotechnology, Retail, Health, Consumer, Online Retail, Environment, Sustainability, Agriculture, Natural Resources, Fitness & Nutrition, Green Technology, Veterinary, Food, Beverage, Pets, Multimedia, Fermentation, Cheese, Plus, Dog, Enzyme, Carbon, Hill, Animal, Computer science and engineering, CO2, Protein, Veterinary medicine, Cat, Pet

View the full release here: https://www.businesswire.com/news/home/20240205535861/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240205535861/en/
    Bond Pet Foods is pioneering the first precision fermentation made meat proteins for the pet food industry.
  • Bond has delivered two tons of its sustainable meat protein ingredient to collaboration partner Hill's Pet Nutrition.
  • (Photo: Business Wire)
    Separately, the companies announced a second joint development agreement to create an additional animal protein for potential use in Hill’s products.
  • The two metric tons produced by Bond represents a major milestone toward commercializing its fermentation technology for pet food applications.

IDEXX Announces Fourth Quarter and Full Year Results

Retrieved on: 
Monday, February 5, 2024
Health, Medical Devices, Consumer, Technology, Software, Pets, Veterinary, EPS, Growth, International, Water, LPD, Idexx Laboratories, Investment, IDXX, CAG, Laboratory

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results.

Key Points: 
  • IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results.
  • Earnings per diluted share (“EPS”) were $2.32 for the fourth quarter, an increase of 13% as reported and 17% on a comparable basis.
  • Results reflect operating margin contraction of 10 basis points as reported and expansion of 60 basis points on a comparable basis.
  • Fourth quarter EPS included $0.04 per share negative impact from currency changes and $0.02 per share in tax benefits from share-based compensation.

Patterson Companies Elects Pamela Tomczik to Board of Directors

Retrieved on: 
Friday, February 2, 2024
Health, Dental, Veterinary, Thomson Reuters, Senior, Committee on Finance, Patterson Companies, Corporate development, Hamline University, University, Treasury, Traveler, M&A, Management

Patterson Companies, Inc. (Nasdaq: PDCO) today announced that Pamela Tomczik has been elected to the Patterson Companies Board of Directors, effective February 2, 2024.

Key Points: 
  • Patterson Companies, Inc. (Nasdaq: PDCO) today announced that Pamela Tomczik has been elected to the Patterson Companies Board of Directors, effective February 2, 2024.
  • “As we continue to enhance the finance, strategy and corporate development experience on our Board, we are excited to welcome Pamela to the Board of Directors,” said John D. Buck, Chairman of the Board of Patterson Companies.
  • “Pamela is a skilled finance executive with extensive experience in the treasury and M&A functions at various companies and will provide valuable strategic insights and enhance the diversity of perspectives on our Board.
  • Prior to joining Target, Ms. Tomczik held several leadership positions at Thomson Reuters, including Vice President of Corporate Development.

Adtalem Global Education Counters Safkhet Capital Report

Retrieved on: 
Thursday, February 1, 2024
Veterinary, Nursing, Health, Mental Health, Continuing, University, Education, Other Health, Nature, Walden University, African Americans, Policy, Growth, Seshat, Corinthian Colleges, Research, AI, DeVry University, MD, Government, AUC, ED, ATGE, PPA, Faculty, Title IV, Professional, Bankruptcy, RUSM, Compensated emancipation, Veterinary medicine, Acquisition, Higher Learning Commission, Risk, DVM, Student, Face, Higher

Adtalem Global Education, Inc. (NYSE: ATGE) responds to claims in a report released on January 30 from Safkhet Capital.

Key Points: 
  • Adtalem Global Education, Inc. (NYSE: ATGE) responds to claims in a report released on January 30 from Safkhet Capital.
  • Safkhet Capital Assertion: Adtalem should impair its $1.48 billion acquisition of Walden.
  • Safkhet Capital Assertion: Graduation rates and attrition rates across all Adtalem schools are trailing far behind national averages.
  • Safkhet Capital Assertion: We believe the gainful employment rule will likely result in the closure of numerous Adtalem degree programs.

Loyal Launches Nationwide, 1,000-Dog Clinical Trial for Drug to Extend Healthy Lifespan in Senior Dogs

Retrieved on: 
Thursday, February 1, 2024
Veterinary, Research, Pets, Clinical Trials, Biotechnology, Health, Consumer, Pharmaceutical, Science, Partnership, Multimedia, Trial of the century, Human, Safety, Notifiable disease, Dog, Longevity, FDA, Collection, Love, Whippet, Veterinarian, Saliva, Food, Quality of life, Animal Hospital, Veterinary medicine, Pharmaceutical industry

LOY-002 is being developed by Loyal to extend the healthy lifespan of senior dogs and maintain their quality of life as they age.

Key Points: 
  • LOY-002 is being developed by Loyal to extend the healthy lifespan of senior dogs and maintain their quality of life as they age.
  • The company recently announced a historic milestone in bringing its LOY-001 drug to market to extend lifespan in large-breed dogs.
  • LOY-002 expands the canine population eligible for a Loyal product to senior dogs of all but the smallest sizes.
  • “There are more than 15 million senior dogs in the United States — including my much-loved senior Rottweiler, Della,” said Halioua.

Carson&Bear™ Dog Wellness Program Unveils "Boost Your Bowl" in New Year’s Challenge for Healthier Dogs and their Owners in 2024

Retrieved on: 
Thursday, February 1, 2024
Online Retail, Other Retail, Specialty, Consumer, Apps, Applications, Technology, Food, Beverage, Fitness & Nutrition, Retail, Veterinary, Health, Pets, Nutrient, Diet, Bear, Love, Inflammation, Parent, Habit, Bowl, Longevity, Pet, Dog, Pet industry

In a challenge to pet parents who want more years with their canine companion, Carson&Bear™ Dog Wellness Program is offering a boost to a healthier 2024.

Key Points: 
  • In a challenge to pet parents who want more years with their canine companion, Carson&Bear™ Dog Wellness Program is offering a boost to a healthier 2024.
  • The "Boost Your Bowl" challenge helps pet owners start a journey of enhanced well-being by using more fresh food for both their dogs and themselves.
  • The initiative celebrates the shared health benefits of fresh, natural foods in the diets of dogs and their human companions.
  • The challenge is also a gentle nudge for pet owners to reassess their dietary habits, aligning their health journey with their pets.